PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
34.52%
Revenue growth above 1.5x MRVL's 13.29%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
33.80%
Gross profit growth above 1.5x MRVL's 18.86%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
65.60%
EBIT growth above 1.5x MRVL's 4.72%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
65.60%
Operating income growth above 1.5x MRVL's 4.72%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
63.05%
Net income growth above 1.5x MRVL's 5.00%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
50.00%
EPS growth above 1.5x MRVL's 4.35%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
80.00%
Diluted EPS growth above 1.5x MRVL's 4.35%. David Dodd would see if there's a robust moat protecting these shareholder gains.
23.13%
Slight or no buybacks while MRVL is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
4.21%
Slight or no buyback while MRVL is reducing diluted shares. John Neff might consider the competitor’s approach more shareholder-friendly.
No Data
No Data available this quarter, please select a different quarter.
144.30%
OCF growth under 50% of MRVL's 5620.88%. Michael Burry might suspect questionable revenue recognition or rising costs.
-1960.10%
Negative FCF growth while MRVL is at 570.40%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
228.72%
10Y revenue/share CAGR above 1.5x MRVL's 4.67%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
228.72%
5Y revenue/share CAGR above 1.5x MRVL's 4.67%. David Dodd would look for consistent product or market expansions fueling outperformance.
228.72%
3Y revenue/share CAGR above 1.5x MRVL's 4.67%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
660.31%
10Y OCF/share CAGR in line with MRVL's 701.90%. Walter Schloss would see both as similarly efficient over the decade.
660.31%
5Y OCF/share CAGR is similar to MRVL's 701.90%. Walter Schloss might see parallel cost profiles or expansions producing comparable cash flow.
660.31%
3Y OCF/share CAGR similar to MRVL's 701.90%. Walter Schloss might see both benefiting from a rising tide or parallel expansions.
322.69%
Net income/share CAGR above 1.5x MRVL's 75.85% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
322.69%
5Y net income/share CAGR above 1.5x MRVL's 75.85%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
322.69%
3Y net income/share CAGR above 1.5x MRVL's 75.85%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
419.51%
Positive growth while MRVL is negative. John Neff might see a strong advantage in steadily compounding net worth over a decade.
419.51%
Positive 5Y equity/share CAGR while MRVL is negative. John Neff might see a clear edge in retaining earnings or managing capital better.
419.51%
Positive short-term equity growth while MRVL is negative. John Neff sees a strong advantage in near-term net worth buildup.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
25.23%
Our AR growth while MRVL is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
77.51%
We show growth while MRVL is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
20.51%
Positive asset growth while MRVL is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
1.59%
Positive BV/share change while MRVL is negative. John Neff sees a clear edge over a competitor losing equity.
-0.39%
We’re deleveraging while MRVL stands at 0.00%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
0.32%
R&D dropping or stable vs. MRVL's 14.00%. David Dodd sees near-term margin benefits if the product pipeline is already strong.
36.46%
SG&A growth well above MRVL's 2.83%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.